甲状腺剤の英語

(a)ほぼ6から24カ月の期間にわたる副甲状腺ホルモンの投与、および(b)副甲状腺ホルモンの投与終了後のほぼ12から36カ月の期間にわたる骨吸収抑制剤の投与に関して適合化された製剤である、副甲状腺ホルモンおよび骨吸収抑制剤を含む複合型薬学的製剤。例文帳に追加

A combined pharmaceutical preparation comprising a parathyroid hormone and a bone resorption inhibitor is a preparation adapted to (a) administration of the parathyroid hormone over the term of about 6 to 24 months and (b) administration of the bone resorption inhibitor over the term of about 12 to 36 months after finishing administration of the parathyroid hormone. - 特許庁

本発明に係る、有機ハロゲン系化合物の代謝排泄促進剤は、３，５，３’−トリヨードサイロキシン（Ｔ３）やサイロキシン（Ｔ４）などの甲状腺ホルモンや、甲状腺刺激ホルモン（ＴＳＨ）などの、甲状腺ホルモン様作用を有する化合物を有効成分とする医薬製剤である。例文帳に追加

The metabolism and excretion promoter for organohalogen-based compounds is a pharmaceutical preparation containing as the active ingredient a compound having thyroid hormone-like activity such as a thyroid hormone like 3,5,3'-triiodothyroxine(T3) or thyroxine(T4) or thyroid-stimulating hormone(TSH). - 特許庁

優れた副甲状腺ホルモン抑制効果のある天然物からなる抑制剤を提供する。例文帳に追加

To obtain an inhibitor comprising a natural product having an excellent inhibitory effect on parathyroid hormone. - 特許庁

自己免疫性甲状腺疾患，ホルモン生成欠陥，甲状腺切除術，先天性甲状腺機能低下症からの原発性甲状腺機能低下症（original hypothyroidism），及び，例えば甲状腺機能低下症，非甲状腺性全身疾患，絶食（fast），セレン不足等によって生じたＩ型５’−ヨードチロニンモノ脱ヨード酵素（Ｉ型ＭＤ）の活性低下等に起因する何らかの障害等の，トリヨードチロニン（Ｔ３）の有機物欠乏症に起因する病状等を治療するのに有効な薬剤を提供する。例文帳に追加

To provide a drug effective for the treatment of pathologies due to organic deficiency of triiodothyronine (T3), for example, original hypothyroidism from autoimmune thyroid diseases, hormonal production defects, thyroidectomy, congenital hypothyroidism, as well as some disorders due to reduced activity of type I 5'-iodothyronine monodeiodinase (type I MD) which is induced, for example, by hypothyroidism, non thyroidal systemic illnesses, fast, and selenium shortage. - 特許庁

甲状腺中毒症による一過的な肝機能検査異常と、抗甲状腺剤による薬剤性肝障害とを、血液検査などにより、簡便にかつ特異的に区別して検出する方法を提供する。例文帳に追加

To provide a method for readily and specifically distinguishing for detecting transient abnormalities in liver function inspection, due to thyroid-gland poisoning and drug hepatopathy caused by an anti-thyroid agent by using a blood test. - 特許庁

カルシトニン及び副甲状腺ホルモンを組み合わせた、週１回投与用、骨疾患の予防及び／又は治療用の医薬複合剤。例文帳に追加

The pharmaceutical compound agent for preventing and/or treating osteopathy comprises a combination of calcitonin with a parathyroid hormone, being intended for a single administration per week. - 特許庁

副甲状腺ホルモン（ＰＴＨ）またはＰＴＨ誘導体を主成分とする、骨髄細胞または骨芽細胞移植医療用補助剤。例文帳に追加

The therapeutic period for bone fracture or bone defection can be shortened by promoting the bone reconstitution with the adjuvant for augmentation therapy using myeloid cells and osteoblast cells mainly including the parathyroid hormone (PTH) or a PTH derivative. - 特許庁

ＴＲ−αまたはＴＲ−βに、５×１０^−６Ｍ未満の結合解離定数Ｋ_ｄで結合する、甲状腺ホルモン化合物または甲状腺ホルモン様アゴニスト化合物、及び、局所塗布に適した薬理学的に許容可能な基剤を含む美白剤。例文帳に追加

There are provided a thyroid hormone or a thyroid hormone-like agonist compound binding to either TR-α or TR-β with a binding dissociation constant K _d less than 5×10^-6 M, and a whitening agent containing a pharmacologically acceptable base suitable for a topical application. - 特許庁